Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype
| dc.contributor.author | Porter, Ross J | |
| dc.contributor.author | Murray, Graeme I | |
| dc.contributor.author | Price, Daniel P | |
| dc.contributor.author | Petty, Russell D | |
| dc.contributor.author | McLean, Mairi H | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2020-06-12T23:07:08Z | |
| dc.date.available | 2020-06-12T23:07:08Z | |
| dc.date.issued | 2020-02-18 | |
| dc.description | The preparation of this paper was funded in part by the Pathological Society of Great Britain and Ireland (intercalated degree educational studentship to R.J.P.). All data is published within this paper and within accompanying supporting files (indicated in text) and accessed via weblink on the journal site. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 1104536 | |
| dc.identifier | 153509858 | |
| dc.identifier | c3b20b66-674f-4423-ad2f-aa242592bf4b | |
| dc.identifier | 85076588239 | |
| dc.identifier | 000515028200012 | |
| dc.identifier.citation | Porter, R J, Murray, G I, Price, D P, Petty, R D & McLean, M H 2020, 'Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype', British Journal of Cancer, vol. 122, pp. 545-554. https://doi.org/10.1038/s41416-019-0685-1 | en |
| dc.identifier.doi | 10.1038/s41416-019-0685-1 | |
| dc.identifier.issn | 0007-0920 | |
| dc.identifier.other | ORCID: /0000-0003-3981-2420/work/76973688 | |
| dc.identifier.other | ORCID: /0000-0002-7443-2653/work/76974208 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14495 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85076588239&partnerID=8YFLogxK | en |
| dc.identifier.vol | 122 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | British Journal of Cancer | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Barrett’s oesophagus | en |
| dc.subject | oesophageal cancer | en |
| dc.subject | HMGB1 | en |
| dc.subject | lymphocytes | en |
| dc.subject | biomarker | en |
| dc.subject | epithelial cell | en |
| dc.subject | DIAGNOSIS | en |
| dc.subject | GRADE DYSPLASIA | en |
| dc.subject | MANAGEMENT | en |
| dc.subject | PROGNOSIS | en |
| dc.subject | ADENOCARCINOMA | en |
| dc.subject | CANCER | en |
| dc.subject | P53 | en |
| dc.subject | THERAPY | en |
| dc.subject | BRITISH SOCIETY | en |
| dc.subject | RADIOFREQUENCY ABLATION | en |
| dc.subject | R Medicine | en |
| dc.subject | Oncology | en |
| dc.subject | Cancer Research | en |
| dc.subject.lcc | R | en |
| dc.title | Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Porter_etal_Novel_biomarkers_for_VOR.pdf
- Size:
- 1.05 MB
- Format:
- Adobe Portable Document Format
